• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday

    11/18/22 2:43:28 AM ET
    $ARDX
    $BBWI
    $CSCO
    $DSX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $ARDX alert in real time by email

    U.S. stocks closed slightly lower on Thursday, with the S&P 500 dropping around 0.3%. Here is the list of some big stocks recording gains in the previous session.

    • Satixfy Communications Ltd. (NYSE:SATX) jumped 96.4% to settle at $51.70 on Thursday.
    • Ardelyx Inc (NASDAQ:ARDX) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
    • Atour Lifestyle Holdings Limited (NASDAQ:ATAT) climbed 31% to close at $14.92.
    • NWTN Inc. (NASDAQ:NWTN) gained 29.8% to settle at $4.10.
    • Bath & Body Works, Inc. (NYSE:BBWI) jumped 25.2% to settle at $38.97 after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
    • Cartesian Growth Corporation (NASDAQ:GLBL) shares climbed 20.9% to close at $10.41 after dropping over 15% on Wednesday.
    • RLX Technology Inc. (NYSE:RLX) rose 20.1% to close at $1.73 after the company reported Q3 financial results.
    • Fossil Group, Inc. (NASDAQ:FOSL) jumped 15.5% to close at $5.28. Fossil Group recently reported better-than-expected Q3 sales results.
    • Macy's, Inc. (NYSE:M) surged 15% to close at $22.67 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 EPS guidance.
    • Priority Technology Holdings, Inc. (NASDAQ:PRTH) gained 13.8% to close at $5.36. Stephen W Hipp, Board Member at Priority Tech, reported a large insider buy on November 16, according to a new SEC filing.
    • Tencent Music Entertainment Group (NYSE:TME) jumped 13.1% to settle at $5.96 amid strength in Alibaba, which gained following Q2 results.
    • Energy Vault Holdings, Inc. (NYSE:NRGV) gained 12.9% to close at $4.02. nergy Vault recently reported quarterly losses of $0.21 per share.
    • Perfect Corp. (NYSE:PERF) surged 11.4% to settle at $9.95.
    • i3 Verticals, Inc. (NASDAQ:IIIV) gained 10% to settle at $24.50 after the company reported Q4 earnings results and issued FY23 guidance.
    • PepGen Inc. (NASDAQ:PEPG) gained 9.9% to close at $16.48.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) jumped 9.4% to close at $31.16. Shoals Technologies recently reported better-than-expected Q3 EPS and sales results.
    • Diana Shipping Inc. (NYSE:DSX) rose 9.2% to close at $4.410 after the company reported better-than-expected Q3 EPS and sales results.
    • Hillenbrand, Inc. (NYSE:HI) gained 8% to close at $48.05 following upbeat Q4 results.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 5% to close at $46.59 after the company reported better-than-expected Q1 results.
    Get the next $ARDX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARDX
    $BBWI
    $CSCO
    $DSX

    CompanyDatePrice TargetRatingAnalyst
    Fossil Group Inc.
    $FOSL
    2/19/2026$7.00Outperform
    Northland Capital
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    Macy's Inc
    $M
    1/14/2026$27.00Buy
    Jefferies
    Bath & Body Works Inc.
    $BBWI
    1/14/2026$24.00Hold
    Jefferies
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    Bath & Body Works Inc.
    $BBWI
    1/8/2026$21.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Coulter Suzanne M bought $101,975 worth of shares (28,170 units at $3.62), increasing direct ownership by 40% to 98,457 units (SEC Form 4)

    4 - Fossil Group, Inc. (0000883569) (Issuer)

    12/4/25 4:41:04 PM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    CFO Greben Randy J bought $49,932 worth of shares (20,980 units at $2.38), increasing direct ownership by 14% to 170,980 units (SEC Form 4)

    4 - Fossil Group, Inc. (0000883569) (Issuer)

    11/25/25 8:01:15 PM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    $ARDX
    $BBWI
    $CSCO
    $DSX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $BBWI
    $CSCO
    $DSX
    SEC Filings

    View All

    SEC Form 144 filed by Ardelyx Inc.

    144 - ARDELYX, INC. (0001437402) (Subject)

    2/24/26 4:30:45 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Shoals Technologies Group Inc.

    10-K - Shoals Technologies Group, Inc. (0001831651) (Filer)

    2/24/26 7:52:53 AM ET
    $SHLS
    Semiconductors
    Technology

    Shoals Technologies Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Shoals Technologies Group, Inc. (0001831651) (Filer)

    2/24/26 7:15:27 AM ET
    $SHLS
    Semiconductors
    Technology

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Splunk Report: Agentic AI Takes Center Stage in CISOs' Path to Digital Resilience

    Nearly all CISOs Report They Are Now Responsible for AI Governance and Risk Management, Cite the Growing Sophistication of Threat Actor Capabilities as Their Greatest RiskVast Majority Say AI Enables More Security Events to be Reviewed SAN JOSE, Calif., Feb. 24, 2026 /PRNewswire/ -- Cisco today announced the release of Splunk's annual report, The CISO Report: From Risk to Resilience in the AI Era, surveying 650 global Chief Information Security Officers (CISOs). The report highlights CISOs' rapidly expanding role, their strategic approach to AI adoption, and a steadfast commitment to human talent as they confront an increasingly complex landscape.

    2/24/26 8:00:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions

    DAYTONA BEACH, Fla. and WALTHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Ladies Professional Golf Association (LPGA) and Ardelyx (NASDAQ:ARDX), a biopharmaceutical company with a vision of creating a healthier tomorrow for patients, today announced a multi-year partnership naming Ardelyx as an official corporate pharmaceutical Marketing Partner of the LPGA Tour. The exclusive partnership unites two organizations dedicated to empowering women to take control of their health. "This partnership represents a natural alignment between Ardelyx's mission and the LPGA's platform to support the digestive health of women, who account for more than 90 percent of those living with conditions lik

    2/24/26 8:00:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator

    PORTLAND, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. ("Shoals") (NASDAQ:SHLS), a global leader in electrical infrastructure solutions for the energy transition market, and ON.energy, a developer of custom grid-safe power architecture, today announced an agreement to deploy multiple gigawatts of critical power systems into the AI data center market. AI and cloud workloads are accelerating data center growth and raising the bar for power reliability, build speed, and operational continuity. This agreement brings together two U.S. innovators with complementary strengths in power architecture and execution. "AI data centers don't just need more power. They nee

    2/24/26 7:00:00 AM ET
    $SHLS
    Semiconductors
    Technology

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Fossil with a new price target

    Northland Capital initiated coverage of Fossil with a rating of Outperform and set a new price target of $7.00

    2/19/26 7:14:48 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Bishop John E sold $18,586 worth of shares (3,179 units at $5.85), decreasing direct ownership by 0.93% to 339,151 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 8:54:33 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Reilly Joseph James sold $29,181 worth of shares (4,991 units at $5.85), decreasing direct ownership by 3% to 151,790 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 8:54:10 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Financials

    Live finance-specific insights

    View All

    Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025

    – Record Quarterly Revenue of $148.3 million – – Quarterly Operating Profit of $17.4 million – – Quarterly Net Income of $8.1 million – – Quarterly Adjusted EBITDA1 of $30.3 million – – Record Backlog and Awarded Orders of $747.6 million – – Provides First Quarter and Full Year 2026 Outlook – PORTLAND, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. ("Shoals" or the "Company") (NASDAQ:SHLS), a leading provider of electrical balance of system ("EBOS") solutions and components, including battery energy storage solutions ("BESS"), and Original Equipment Manufacturer ("OEM") components for the global energy transition market, today announced results for its fourt

    2/24/26 7:00:00 AM ET
    $SHLS
    Semiconductors
    Technology

    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million Patient-first XPHOZAH strategy preserved access and drove growth in total dispenses Development programs for new IBSRELA indication and next-generation NHE3 inhibitor launched Company is well capitalized to meet current business objectives Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year

    2/19/26 4:01:00 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bath & Body Works to Report Fourth Quarter and Fiscal 2025 Results on March 4, 2026

    COLUMBUS, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today that it plans to report its fourth quarter and fiscal 2025 financial results before market open on Wednesday, March 4, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company's website at bbwinc.com. Investors and a

    2/18/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PepGen Inc.

    SC 13G/A - PepGen Inc. (0001835597) (Subject)

    11/14/24 4:31:29 PM ET
    $PEPG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ardelyx Inc.

    SC 13G/A - ARDELYX, INC. (0001437402) (Subject)

    11/14/24 4:08:33 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bath & Body Works Inc.

    SC 13G/A - Bath & Body Works, Inc. (0000701985) (Subject)

    11/14/24 1:28:29 PM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ARDX
    $BBWI
    $CSCO
    $DSX
    Leadership Updates

    Live Leadership Updates

    View All

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    FOSSIL GROUP, INC. APPOINTS SHANNON FREEZE AS CHIEF PEOPLE AND COMMUNICATIONS OFFICER

    RICHARDSON, Texas, Feb. 9, 2026 /PRNewswire/ -- Fossil Group, Inc. (NASDAQ:FOSL) ("Fossil" or the "Company") today announced the appointment of Shannon Freeze as Chief People and Communications Officer and a member of the Executive Leadership Team, reporting to CEO Franco Fogliato, effective February 23, 2026. In this role, she will oversee global communications and engagement, diversity and belonging, human resources, talent management, and total rewards. "We're thrilled to welcome Shannon to Fossil Group. As Chief People and Communications Officer and a member of the Executi

    2/9/26 9:00:00 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

    PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Joseph Vittiglio, Esq., as Chief Business and Legal Officer. Mr. Vittiglio brings more than two decades of executive leadership experience across legal, compliance, corporate development, and corporate governance within public biotechnology companies. "Joe is a deeply experienced legal and business leader with a proven track record guiding companies through complex transactions, regulatory milestones, financings, product launches, and stra

    12/8/25 7:00:00 AM ET
    $PEPG
    Biotechnology: Pharmaceutical Preparations
    Health Care